Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Endocrine 1

Conditions

Pituitary ACTH Hypersecretion 1Neoplasms 1Cushing Syndrome 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Perceived Stress Scale × 1 year × Clear all
NCT07326800 2026-04-16

MAEva-MCT

Institut de Cancérologie de Lorraine

Phase NA Recruiting
190 enrolled
Tumor-Agnostic

Neoplasms

NCT03364803 2025-10-23

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Memorial Sloan Kettering Cancer Center

Recruiting
300 enrolled
Endocrine

Cushing Syndrome, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡